Articles On Nanollose (ASX:NC6)

Title Source Codes Date
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead NC6 4 days ago
Closing Bell: Local markets ride commodities higher after a blow to US confidence on Friday

  Local markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200 benchmark finished the day on +0.09pc, a lot higher than it really had any right to Resources led the way, overcoming a significant deadwei...

Stockhead NC6 1 week ago
Closing Bell: Blood plasma giant CSL bleeds out in front of entire ASX on Monday

  ASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small cap winners led by American Rare Earths and Appen   The benchmark was shot through the heart by CSL this morning leaving everything else in...

Stockhead NC6 2 weeks ago
Top 10 at 11: Boardroom battles and spinning drills are driving the market this morning

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead NC6 3 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead NC6 3 months ago
Closing Bell: Friday takes a bite out of ASX, even as biotech and lithium small caps run amok

The ASX has ended the week lower, down 0.55pc on Friday Healthcare Sector remains defiant  Small caps led by medtech names and Lake Johnston lithium hunters   The fickle Aussie sharemarket has given back on Friday all that it has made thi...

Stockhead NC6 3 months ago
Closing Bell: ASX in disgrace after crashing to 12-month low

Benchmark ASX index ends -0.6 lower Utilities only sector in the green Small caps led by LSA, AZS   The ASX200 has closed 42 points (-0.61%) lower on Thursday. May as well get you a pic. I’ll point out the important bits…   ASX200 ON THUR...

Stockhead NC6 4 months ago
Closing Bell: ASX ends flat, but it’s not a good flat. More an Oxford Dictionary ‘to lack vigour; dull and lifeless’ flat

Benchmark ASX index closes short by -0.04% Materials sector tries but cannot offset everyone else  Small caps led by HAL, DTC   The ASX200 Index has closed slightly lower after jumping early (+0.3%) out the gates on Wednesday morning. The...

Stockhead NC6 4 months ago
Closing Bell: ASX unconvincing ahead of big CPI read and maiden address by new RBA boss

Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW, NMR   Local markets have struggled to hang onto early gains after a mixed run on Wall Street overnight. The benchmark ASX200 (XJO) index...

Stockhead NC6 4 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead NC6 4 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead NC6 5 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead NC6 5 months ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead NC6 6 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead NC6 6 months ago
Top 10 at 10-ish: Great White win for Andromeda, but things aren’t so great for EMS

Stockhead’s Top 10 at 11, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead NC6 6 months ago
Closing Bell: ASX rises despite tech meltdown; Domino’s fires everyone, stock jumps

ASX 200 benchmark climbs 0.5% Tech Sector plunges 5.5% while Consumer stocks and iron ore majors save day  Small cap gains led by huge day at 4DS   The Australian share market extracted some green from a dull Wednesday wicket after the Wa...

Stockhead NC6 6 months ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead NC6 6 months ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead NC6 7 months ago
In Case You Missed It: Data centres, gold and cannabis take the lead

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 7 months ago
CLOSING BELL: ASX rises 1.5pc today, with the Goldies out in front on 3.54pc

ASX snaps a 4-day run of bruising luck with a welcome 1.5% gain Techies did a lot of the heavy lifting, while the Goldies put on a +3.54% show The day’s clear winner was Mobilicom, up 150% at day’s end on juicy defence news   Local market...

Stockhead NC6 7 months ago
CLOSING BELL: ASX falters with no US market to copy today

S&P/ASX 200 closes in the red today: -0.35%, as US stock markets enjoy a July 4 chilli dog, or something Sectors-wise, Telcos are ringing in the gainz… annnd that’s about it. Okay, Utilities are going alright  Standout stocks: Krakatoa...

Stockhead NC6 7 months ago
In Case You Missed It: Lithium, nickel and a Peruvian divestment deal

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 7 months ago
In Case You Missed It: Rare earths, lithium and a dash of nickel

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 8 months ago
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead NC6 8 months ago
In Case You Missed It: Gold, rare earths and a digital healthcare deal

Stockhead’s In-Case-You-Missed-It highlights some strongest-performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 8 months ago
In Case You Missed It: Lithium, iron ore, and iron ore switching to lithium

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 8 months ago
Less swings, more roundabouts for these ASX companies driving the circular economy

Several ASX companies are driving Australia’s circular economy, prioritising resource conservation and sustainability Nanollose is working to produce tree-free cellulose, instead using an eco-friendly fermentation process to grow fibres...

Stockhead NC6 8 months ago
In Case You Missed It: Nickel hits, Canadian lithium and some more nickel

Stockhead’s In-Case-You-Missed-It highlights some strongest-performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 8 months ago
In Case You Missed It: Tech takeover takes the cake  

Stockhead’s In-Case-You-Missed-It highlights some of the strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentag...

Stockhead NC6 8 months ago
In Case You Missed It: Spectacular gold, an authentication deal and some lithium

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 8 months ago
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead NC6 8 months ago
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead NC6 9 months ago
In Case You Missed It: Lithium takes the lead, followed by biotech and manganese today

Stockhead’s In-Case-You-Missed-It highlights some of the strongest-performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentag...

Stockhead NC6 9 months ago
CLOSING BELL: Can you guess which company we all gave $2.7bn to announced a record $2.5bn profit today?

The ASX closed out the day flat, thanks to a last-minute selling spree Qantas announces record profit but still won’t give us back the money we gave them during Covid Westar Resources won the Small Caps race, in spite of a 90-minute hobbli...

Stockhead NC6 9 months ago
ASX Health Stocks: 4DMedical makes breakthrough, potentially disrupts century-old method

4DMedical  announced a significant breakthrough in imaging technology Bod Australia announced updates on its Aqua Phase Delivery technology Nanollose to strengthen balance sheet after receiving R&D tax rebate   4DMedical says its CT t...

Stockhead NC6 9 months ago
In Case You Missed It: Zinc, gold and lithium take the cake today

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 9 months ago
In Case You Missed It: High-grade lithium results and a massive 1.3Moz gold resource

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Stockhead NC6 9 months ago
Nanollose files patent for breakthrough in microbial cellulose technology

Biomaterial tech company Nanollose is adding to its growing portfolio of intellectual property, filing a new provisional patent application with IP Australia, this time for its alternative seed germination and plant growing material Jelli G...

Stockhead NC6 9 months ago
In Case You Missed it: Medicinal cannabis acquisitions and double digit gold grades

Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage...

Stockhead NC6 9 months ago
In Case You Missed It: Rare earth riches are enjoying their time in the sun

Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage...

Stockhead NC6 9 months ago
In Case You Missed It: Rare earth discoveries sends one small cap spinning and a $3m engine contract deal

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Stockhead NC6 9 months ago
In Case You Missed It: Lithium, Rare earths, and nickel news to feast your eyes on

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Stockhead NC6 10 months ago
In Case You Missed It: Niobium hits and a big battery metals offtake deal

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 10 months ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead NC6 10 months ago
In Case You Missed It: Lithium, edtech in India and base metals players hit the gas

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead NC6 10 months ago
Nanollose completes second pilot spin of ground-breaking, tree-friendly, Nullarbor lyocell fibre

Nanollose has completed its second pilot spin of its sustainable Nullarbor lyocell fibre, successfully increasing the microbial cellulose content. Australia-based biomaterial technology company Nanollose (ASX:NC6) has completed a milestone...

Stockhead NC6 11 months ago
CLOSING BELL: Brace yourselves… even the clowns in charge don’t know what’s coming.

Benchmark set to finish close to flat as Energy stocks slump again Goldies are surging again, with that sector up 1.3% for the day Even the big banks are bracing for trouble with talk of a crisis getting louder by the day   After a modera...

Stockhead NC6 11 months ago
Nanollose extends deal with partner Grasim Industries as works to commercialise tree-free fibre

Nanollose has extended its deal with fibre manufacturing conglomerate Grasim Industries as it works to get its forest-friendly Nullarbor fibres to market. Australia-based biomaterial technology company Nanollose (ASX:NC6) has announced it...

Stockhead NC6 11 months ago
CLOSING BELL: Who knew you could still make money from inside a burning dumpster?

ASX hammered as bank-driven fear grips the market like a python round a possum XEC Emerging Companies falls more than 2.0% because they’re young and don’t know any better Safe haven goldies still managed to make bank. Sorry… poor choice of...

Stockhead NC6 11 months ago
Nanollose secures milestone US patent for sustainable fibre technology

Nanollose has achieved another key milestone as it works to help the fashion world become more eco-friendly and develop fibres with minimal environmental impact. Australia-based biomaterial technology company Nanollose (ASX:NC6) has secured...

Stockhead NC6 11 months ago